For: | Kayikcioglu E, Yüceer RO, Cetin B, Yüceer K, Karahan N. Prognostic value of claudin 18.2 expression in gastric adenocarcinoma. World J Gastrointest Oncol 2023; 15(2): 343-351 [PMID: 36908327 DOI: 10.4251/wjgo.v15.i2.343] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v15/i2/343.htm |
Number | Citing Articles |
1 |
Izuma Nakayama, Changsong Qi, Yang Chen, Yoshiaki Nakamura, Lin Shen, Kohei Shitara. Claudin 18.2 as a novel therapeutic target. Nature Reviews Clinical Oncology 2024; 21(5): 354 doi: 10.1038/s41571-024-00874-2
|
2 |
Aynur IŞIK, Güneş GÜNER, Can ZEYNELOĞLU, Seçil DEMİRKOL CANLI, Hakki TASTAN, Aytekin AKYOL. Claudin 18.2 Expression in Gastric Adenocarcinomas in a Large Turkish Cohort. Bolu Abant Izzet Baysal Universitesi Tip Fakultesi Abant Tip Dergisi 2023; 12(2): 5 doi: 10.47493/abantmedj.1313791
|
3 |
Xiao-Yu Wang, De-Fan Yao, Gang Ren. Progress in research of tumor biomarkers and molecular imaging probes for gastric cancer. World Chinese Journal of Digestology 2024; 32(1): 1 doi: 10.11569/wcjd.v32.i1.1
|
4 |
Maria Cecília Mathias-Machado, Victor Hugo Fonseca de Jesus, Alexandre Jácome, Mauro Daniel Donadio, Marcelo Porfirio Sunagua Aruquipa, João Fogacci, Renato Guerino Cunha, Leonard Medeiros da Silva, Renata D’Alpino Peixoto. Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?. Cancers 2024; 16(3): 679 doi: 10.3390/cancers16030679
|